Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audra R Fullen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Plos Pathogens|July 24, 2020
Whoop! There it is: The surprising resurgence of pertussisAudra R Fullen, Kacy S Yount, Purnima Dubey, et al.
Infection and Immunity|July 17, 2019
<i>Bordetella</i> Colonization Factor A (BcfA) Elicits Protective Immunity against Bordetella bronchiseptica in the Absence of an Additional AdjuvantKacy S Yount, Jamie Jennings-Gee, Kyle Caution, et al.
Cell Reports|March 5, 2020
Continuous Microevolution Accelerates Disease Progression during Sequential Episodes of InfectionAlistair Harrison, Rachael L Hardison, Audra R Fullen, et al.
Plos Pathogens|February 23, 2023
Architecture and matrix assembly determinants of Bordetella pertussis biofilms on primary human airway epitheliumAudra R Fullen, Jessica L Gutierrez-Ferman, Rachael E Rayner, et al.
Frontiers in Immunology|June 5, 2023
Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces Kacy S Yount, Jesse M Hall, Kyle Caution, et al.
Plos Pathogens|August 15, 2022
Bps polysaccharide of Bordetella pertussis resists antimicrobial peptides by functioning as a dual surface shield and decoy and converts Escherichia coli into a respiratory pathogenAudra R Fullen, Jessica L Gutierrez-Ferman, Kacy S Yount, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Antibacterial photosensitization through activation of coproporphyrinogen oxidaseMatthew C Surdel, Dennis J Horvath, Lisa J Lojek, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos Pathogens|July 24, 2020
Whoop! There it is: The surprising resurgence of pertussisAudra R Fullen, Kacy S Yount, Purnima Dubey, et al.
Infection and Immunity|July 17, 2019
<i>Bordetella</i> Colonization Factor A (BcfA) Elicits Protective Immunity against Bordetella bronchiseptica in the Absence of an Additional AdjuvantKacy S Yount, Jamie Jennings-Gee, Kyle Caution, et al.
Cell Reports|March 5, 2020
Continuous Microevolution Accelerates Disease Progression during Sequential Episodes of InfectionAlistair Harrison, Rachael L Hardison, Audra R Fullen, et al.
Plos Pathogens|February 23, 2023
Architecture and matrix assembly determinants of Bordetella pertussis biofilms on primary human airway epitheliumAudra R Fullen, Jessica L Gutierrez-Ferman, Rachael E Rayner, et al.
Frontiers in Immunology|June 5, 2023
Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces Kacy S Yount, Jesse M Hall, Kyle Caution, et al.
Plos Pathogens|August 15, 2022
Bps polysaccharide of Bordetella pertussis resists antimicrobial peptides by functioning as a dual surface shield and decoy and converts Escherichia coli into a respiratory pathogenAudra R Fullen, Jessica L Gutierrez-Ferman, Kacy S Yount, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Antibacterial photosensitization through activation of coproporphyrinogen oxidaseMatthew C Surdel, Dennis J Horvath, Lisa J Lojek, et al.
Pageof 1